Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could a Trump-mandated cash repatriation spur pharma M&A, or just share buybacks?
Could a Trump-mandated cash repatriation spur pharma M&A, or just share buybacks?
Could a Trump-mandated cash repatriation spur pharma M&A, or just share buybacks?
Submitted by
admin
on August 12, 2017 - 12:09pm
Source:
Fierce Pharma
News Tags:
M&A
Donald Trump
tax reform
Headline:
Could a Trump-mandated cash repatriation spur pharma M&A, or just share buybacks?
Do Not Allow Advertisers to Use My Personal information
